Parathyroid hormone-related protein (
PTHrP) is expressed by human prostatic tissue and
prostate cancer cell lines, and positively influences primary prostate
tumor growth in vivo. The human
prostate cancer cell line PC-3, which expresses functional PTH/
PTHrP receptors, was used as a model to study the effects of
PTHrP on
prostate cancer cell growth. Addition of
PTHrP (1-34), (1-86), and (1-139) increased cell number and [3H]
thymidine incorporation; these effects were reversed by anti-
PTHrP antiserum. This antiserum also decreased endogenous PC-3 cell growth. Clonal
PTHrP-overexpressing PC-3 cell lines also showed enhanced cell growth and [3H]
thymidine incorporation and were enriched in the G2+M phase of the cell cycle, suggesting an effect of
PTHrP on mitosis. Overexpression of
PTHrP with the nuclear localization sequence (NLS) deletion partially reversed the growth-stimulatory effects. The growth rate of these cells was midway between that of wild-type
PTHrP-overexpressing and control cells, presumably because NLS-mutated
PTHrP is still secreted and acts through the cell surface
PTH/PTHrP receptor. In contrast to NLS-mutated
PTHrP, wild-type
protein showed preferential nuclear localization. These results suggest that the proliferative effects of
PTHrP in PC-3 cells are mediated via both autocrine/paracrine and intracrine pathways, and that controlling
PTHrP production in
prostate cancer may be therapeutically beneficial.